<DOC>
	<DOCNO>NCT00752661</DOCNO>
	<brief_summary>The purpose study find clinical dose range active ingredient JNS013 - Tramadol hydrochloride chronic-pain patient attain sufficient analgesic effect non-steroidal anti-inflammatory drug ( NSAIDs ) .</brief_summary>
	<brief_title>An Exploratory Study Tramadol Hydrochloride Patients With Osteoarthritis Knee Low Back Pain</brief_title>
	<detailed_description>Since JNS013 combination tramadol hydrochloride ( TRAM ) act weak opioid acetaminophen ( APAP ) inhibit central COX-3 , expect intermediate effect narcotic analgesic NSAIDs ( non-steroid anti-inflammatory drug ) . This multicenter , open-label , dose response study . The purpose study find clinical dose range TRAM patient chronic pain due osteoarthritis ( OA ) knee low back pain ( LBP ) attain sufficient analgesic effect NSAIDs . The investigational product orally administer 4 time daily ( meal bedtime ) dose 25 100 mg least 4-hour interval . Treatment start initial dose 100 mg/day , dose titrate 25 mg every 7 day analgesic effect insufficient problem safety . Treatment continue 35 day total dose 400 mg/day dose sufficient analgesic effect obtain . The primary efficacy endpoint change intensity pain begin dose-finding period ( baseline ) final assessment point ( Up Day 36 ) , use VAS ( Visual Analog Scale ) . The safety evaluation adverse event , laboratory examination , blood pressure/pulse rate body weight . Total study period study 49days , Screening period 7days , Administration period 35 day Follow-up period 7 day . The investigational product orally administer 4 time daily ( meal bedtime ) dose 25 100 mg least 4-hour interval . Treatment start initial dose 100 mg/day , dose titrate 25 mg every 7 day analgesic effect insufficient problem safety . Treatment continue 35 day total dose 400 mg/day dose sufficient analgesic effect obtain .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>Patients chronic pain due OA knee LBP persist 3 month initiation observation period Patients receive oral NSAIDs usual high dose least 14 consecutive day 3 month initiation observation period , could attain sufficient analgesic effect Patients intensity strong pain 48 hour initiation observation period &gt; = 40 mm &lt; 80 mm VAS Ambulatory outpatient Prior conduct study , patient give sufficient explanation investigational product study give consent write participate study . Patients condition opioids contraindicate Patients hypersensitivity opioids Patients receive TRAM past discontinue treatment due ineffectiveness adverse reaction Patients complication associate pain degree consider influence efficacy assessment ( trauma fracture , headache , postherpetic neuralgia ) Patients complication severe spinal disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>low back pain</keyword>
	<keyword>oral drug</keyword>
	<keyword>tramadol</keyword>
</DOC>